Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Catalyst Pharmaceuticals Inc

CPRX
Current price
15.06 USD +0.37 USD (+2.52%)
Last closed 14.82 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 579 975 040 USD
Yield for 12 month -11.31 %
Week
Month
Year
CPRX
21.11.2021 - 28.11.2021

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida. Address: 355 Alhambra Circle, Coral Gables, FL, United States, 33134

Analytics

WallStreet Target Price

23.3 USD

P/E ratio

26.9455

Dividend Yield

5.97 %

Current Year

+214 203 000 USD

Last Year

+140 833 000 USD

Current Quarter

+102 688 000 USD

Last Quarter

+99 582 000 USD

Current Year

+179 810 000 USD

Last Year

+118 949 000 USD

Current Quarter

+88 521 000 USD

Last Quarter

+87 537 000 USD

Key Figures CPRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 100 274 000 USD
Operating Margin TTM -36.22 %
PE Ratio 26.9455
Return On Assets TTM 12.72 %
PEG Ratio
Return On Equity TTM 20.06 %
Wall Street Target Price 23.3 USD
Revenue TTM 348 392 992 USD
Book Value 3.27 USD
Revenue Per Share TTM 3.3 USD
Dividend Share
Quarterly Revenue Growth YOY 79.4 %
Dividend Yield 5.97 %
Gross Profit TTM 160 021 000 USD
Earnings Share 0.55 USD
Diluted Eps TTM 0.55 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY 65 %
Profit Margin 17.81 %

Dividend Analytics CPRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CPRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 5.97 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CPRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 26.9455
Forward PE 10.0301
Enterprise Value Revenue 4.2044
Price Sales TTM 4.535
Enterprise Value EBITDA 14.6078
Price Book MRQ 4.5392

Financials CPRX

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CPRX

For 52 weeks

11.09 USD 22.11 USD
50 Day MA 12.95 USD
Shares Short Prior Month 6 418 245
200 Day MA 13.97 USD
Short Ratio 4.78
Shares Short 6 655 399
Short Percent 7.9 %